Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

NCT03273660 is registered in ClinicalTrials.gov with Derming SRL as lead sponsor.

NCT NCT03273660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03273660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)
Lead sponsor
Derming SRL
Phase
Not applicable
Overall status
Completed
Start date
June 5, 2017
Completion date
March 13, 2018
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malar and sub-malar volume deficiency